Real-Life Tolerability and Effectiveness of Adalimumab Biosimilar in Rheumatoid Arthritis: ASPIRE Registry Data

被引：0
|
作者：
Sanjiv Kapoor
Viswanath V. Kaushik
Rahul Jain
Vijay Rao
Mihir Gharia
机构：
[1] Indian Spinal Injuries Centre,Rheumatology
[2] Arthritis & Rheumatism Centre,Medical Affairs, Zydus Biovation
[3] Narayana Multispeciality Hospital,undefined
[4] Manipal Hospital,undefined
[5] Cadila Healthcare Ltd,undefined
来源：
Rheumatology and Therapy | 2019年 / 6卷
关键词：
Adalimumab; Biosimilar; Real-life; Registry; Rheumatoid Arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：451 / 459
页数：8
相关论文
共 50 条
  • [41] Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry
    Pappas, Dimitrios A.
    Kremer, Joel M.
    Griffith, Jenny
    Reed, George
    Salim, Bob
    Karki, Chitra
    Garg, Vishvas
    [J]. RHEUMATOLOGY AND THERAPY, 2017, 4 (02) : 375 - 389
  • [42] Real-world cost-effectiveness of infliximab, etanercept and adalimumab in rheumatoid arthritis patients: results of the CREATE registry
    Cardenas, M.
    de la Fuente, S.
    Font, P.
    Castro-Villegas, M. C.
    Romero-Gomez, M.
    Ruiz-Vilchez, D.
    Calvo-Gutierez, J.
    Escudero-Contreras, A.
    Casado, M. A.
    Del Prado, J. R.
    Collantes-Estevez, E.
    [J]. RHEUMATOLOGY INTERNATIONAL, 2016, 36 (02) : 231 - 241
  • [43] HIGHER LIKELIHOOD OF RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS TREATED IN A REAL-LIFE SETTING WITH ADALIMUMAB IN COMBINATION WITH METHOTREXATE, BUT NOT WITH OTHER DMARDS, VERSUS ADALIMUMAB MONOTHERAPY
    Kiely, P.
    Florentinus, S.
    Keidel, S.
    Lacerda, A.
    Karunaratne, M.
    McCaskill, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 432 - 433
  • [44] HIGHER LIKELIHOOD OF RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS TREATED IN A REAL-LIFE SETTING WITH ADALIMUMAB IN COMBINATION WITH METHOTREXATE, BUT NOT WITH OTHER DMARDS, VERSUS ADALIMUMAB MONOTHERAPY
    Kiely, Patrick
    Florentinus, Stefan
    Keidel, Sarah
    Karunaratne, Mahinda
    Lacerda, Ana
    [J]. RHEUMATOLOGY, 2014, 53 : 98 - 98
  • [45] EFFECTIVENESS AND SAFETY OF BIOLOGIC AND TARGET SYNTHETIC DRUGS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN THE ERA OF JAK INHIBITORS: A REAL-LIFE STUDY FROM BIOPURE REGISTRY
    Fornaro, M.
    Santo, L.
    Bucci, R. N. G.
    Semeraro, A.
    Carlino, G.
    Quarta, L.
    D'onofrio, F.
    Lazzari, A.
    Serafino, L.
    Marsico, A.
    Zuccaro, C.
    Falappone, P. C. F.
    Mazzotta, D.
    Cantatore, F. P.
    Iannone, F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 732 - 733
  • [46] Replacement of Amlodipine and Lercanidipine by Barnidipine: Tolerability and Effectiveness in a Real-Life Study
    Lins R.
    Haerden Y.
    de Vries C.
    [J]. High Blood Pressure & Cardiovascular Prevention, 2017, 24 (1) : 29 - 36
  • [47] SUBCUTANEOUS ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS: A REAL-LIFE EXPERIENCE
    Sarmiento-Monroy, J. C.
    Rodriguez-Lopez, M.
    Molano-Gonzalez, N.
    Rojas-Villarraga, A.
    Mantilla, R. D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 725 - 725
  • [48] SUBCUTANEOUS ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS: A REAL-LIFE EXPERIENCE
    Sarmiento-Monroy, J. C.
    Villota-Eraso, C.
    Mantilla-Ribero, M. J.
    Molano-Gonzalez, N.
    Rodriguez-Jimenez, M.
    Rojas-Villarraga, A.
    Mantilla, R. D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1024 - 1024
  • [49] SURVIVAL OF ABATACEPT IN RHEUMATOID ARTHRITIS PATIENTS: A REAL-LIFE STUDY
    Molteni, E.
    Ceccarelli, F.
    Castellani, C.
    Giardina, F.
    Alessandri, C.
    Di Franco, M.
    Riccieri, V.
    Spinelli, F. R.
    Scrivo, R.
    Priori, R.
    Conti, F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1143 - 1143
  • [50] ALIGNING CLINICAL TRIALS IN RHEUMATOID ARTHRITIS WITH REAL-LIFE POPULATIONS
    Coy, N. C. Navarro
    West, R. M.
    Pavitt, S. H.
    Hyrich, K.
    Veale, D.
    Emery, P.
    Buch, M. H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 789 - 789
12345